Idioma:

Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage: The UK-REBOA Randomized Clinical Trial

Jansen, Jan O ; Hudson, Jemma ; Cochran, Claire ; MacLennan, Graeme ; Lendrum, Robbie ; Sadek, Sam ; Gillies, Katie ; Cotton, Seonaidh ; Kennedy, Charlotte ; Boyers, Dwayne ; Ferry, Gillian ; Lawrie, Louisa ; Nath, Mintu ; Wileman, Samantha ; Forrest, Mark ; Brohi, Karim ; Harris, Tim ; Lecky, Fiona ; Moran, Chris ; Morrison, Jonathan J ; Norrie, John ; Paterson, Alan ; Tai, Nigel ; Welch, Nick ; Campbell, Marion K ; Aylwin, Chris ; Bew, Duncan ; Brooks, Adam ; Chinery, James ; Cowlam, Tom ; Frith, Dan ; George, Arun ; Hudson, Anthony ; Johnstone, Phillip ; Mahmood, Ansar ; Novak, Alex ; O'Meara, Matt ; Reid, Stuart ; Sattout, Abdo ; Smith, Chris ; Stansfield, Tim ; Thompson, Julian

JAMA : the journal of the American Medical Association, 2023-11, Vol.330 (19), p.1862-1871 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

Citações Citado por

Enviar para

Título:
Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage: The UK-REBOA Randomized Clinical Trial
Autor: Jansen, Jan O ; Hudson, Jemma ; Cochran, Claire ; MacLennan, Graeme ; Lendrum, Robbie ; Sadek, Sam ; Gillies, Katie ; Cotton, Seonaidh ; Kennedy, Charlotte ; Boyers, Dwayne ; Ferry, Gillian ; Lawrie, Louisa ; Nath, Mintu ; Wileman, Samantha ; Forrest, Mark ; Brohi, Karim ; Harris, Tim ; Lecky, Fiona ; Moran, Chris ; Morrison, Jonathan J ; Norrie, John ; Paterson, Alan ; Tai, Nigel ; Welch, Nick ; Campbell, Marion K ; Aylwin, Chris ; Bew, Duncan ; Brooks, Adam ; Chinery, James ; Cowlam, Tom ; Frith, Dan ; George, Arun ; Hudson, Anthony ; Johnstone, Phillip ; Mahmood, Ansar ; Novak, Alex ; O'Meara, Matt ; Reid, Stuart ; Sattout, Abdo ; Smith, Chris ; Stansfield, Tim ; Thompson, Julian
Assuntos: Adult ; Aorta ; Balloon Occlusion - adverse effects ; Balloon Occlusion - methods ; Balloon treatment ; Bayes Theorem ; Bayesian analysis ; Bleeding ; Cardiovascular system ; Caring for the Critically Ill Patient ; Clinical trials ; Complications ; Conditional probability ; Coronary vessels ; Data collection ; Death ; Emergency medical care ; Emergency medical services ; Emergency Service, Hospital ; Exsanguination - complications ; Female ; Hemorrhage ; Hemorrhage - etiology ; Hemorrhage - therapy ; Hospitals ; Humans ; Injury Severity Score ; Male ; Mortality ; Occlusion ; Online First ; Original Investigation ; Patients ; Preventable deaths ; Resuscitation - methods ; Retrospective Studies ; Trauma ; United Kingdom
É parte de: JAMA : the journal of the American Medical Association, 2023-11, Vol.330 (19), p.1862-1871
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Bleeding is the most common cause of preventable death after trauma. To determine the effectiveness of resuscitative endovascular balloon occlusion of the aorta (REBOA) when used in the emergency department along with standard care vs standard care alone on mortality in trauma patients with exsanguinating hemorrhage. Pragmatic, bayesian, randomized clinical trial conducted at 16 major trauma centers in the UK. Patients aged 16 years or older with exsanguinating hemorrhage were enrolled between October 2017 and March 2022 and followed up for 90 days. Patients were randomly assigned (1:1 allocation) to a strategy that included REBOA and standard care (n = 46) or standard care alone (n = 44). The primary outcome was all-cause mortality at 90 days. Ten secondary outcomes included mortality at 6 months, while in the hospital, and within 24 hours, 6 hours, or 3 hours; the need for definitive hemorrhage control procedures; time to commencement of definitive hemorrhage control procedures; complications; length of stay; blood product use; and cause of death. Of the 90 patients (median age, 41 years [IQR, 31-59 years]; 62 [69%] were male; and the median Injury Severity Score was 41 [IQR, 29-50]) randomized, 89 were included in the primary outcome analysis because 1 patient in the standard care alone group declined to provide consent for continued participation and data collection 4 days after enrollment. At 90 days, 25 of 46 patients (54%) had experienced all-cause mortality in the REBOA and standard care group vs 18 of 43 patients (42%) in the standard care alone group (odds ratio [OR], 1.58 [95% credible interval, 0.72-3.52]; posterior probability of an OR >1 [indicating increased odds of death with REBOA], 86.9%). Among the 10 secondary outcomes, the ORs for mortality and the posterior probabilities of an OR greater than 1 for 6-month, in-hospital, and 24-, 6-, or 3-hour mortality were all increased in the REBOA and standard care group, and the ORs were increased with earlier mortality end points. There were more deaths due to bleeding in the REBOA and standard care group (8 of 25 patients [32%]) than in standard care alone group (3 of 18 patients [17%]), and most occurred within 24 hours. In trauma patients with exsanguinating hemorrhage, a strategy of REBOA and standard care in the emergency department does not reduce, and may increase, mortality compared with standard care alone. isrctn.org Identifier: ISRCTN16184981.
Editor: United States: American Medical Association
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 5 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage: The UK-REBOA Randomized Clinical Trial

United States: American Medical Association

Buscando em bases de dados remotas. Favor aguardar.